The first results of the coronavirus vaccine trial are expected from the University of Oxford and AstraZeneca, according to reports.


According to media reports, the first results of the University of Oxford’s AstraZeneca coronavirus vaccine trial are imminently expected.

The BBC reports that data from the initial test will be released on Monday.

Citing people involved in the trial, the Daily Telegraph reported last week that the vaccine could offer a “double defense” against the virus, eliciting both a T-cell response and an antibody response. The Telegraph also reports that data on the trial will be released Monday.

TESTING CORONAVIRUS VACCINES IN THE UK IS ‘PROGRESSING VERY WELL’, RECRUITING CHILDREN AND OLDER ADULTS

Fox News has contacted Oxford University and AstraZeneca with a request for comment on this story.

AstraZeneca shares rose just over 1 percent to $ 61.75 in pre-market trade.

The Oxford University trial is “progressing very well,” said researchers involved in the project in May.

THE INVESTIGATION VACCINE PROTECTS THE MONKEYS AGAINST COVID-19 PNEUMONIA

Separately in May, UK business secretary Alok Sharma said the Oxford vaccine trial, if successful, could deliver 30 million doses in September. The UK government has invested in 100 million doses of vaccines, according to reports.

With 296,358 cases and 45,385 deaths, the United Kingdom is one of the countries most affected by the coronavirus pandemic, according to data compiled by Johns Hopkins University.

Various efforts are underway to develop a coronavirus vaccine worldwide. Scientists at Israel’s Tel Aviv University and the biopharmaceutical company Neovii, for example, recently announced a project to develop a COVID-19 vaccine.

MORE THAN 100 YEARS BEFORE CORONAVIRUSES, THE SPANISH FLU PANDEMIC SPOKEN THE BALLOON

Experts involved in the effort say they are targeting the coronavirus “Achilles’ heel.”

As of Monday morning, more than 14.5 million cases of coronaviruses have been diagnosed worldwide, of which at least 3.7 million are in the U.S., according to Johns Hopkins University.

The disease has accounted for at least 606,206 deaths worldwide, including at least 140,534 people in the U.S.

CLICK HERE TO GET THE FOX NEWS APP

Christopher Carbone of Fox News contributed to this article. Follow James Rogers on Twitter @jamesjrogers